| Boston Scientific Corporation is a worldwide developer, manufacturer and marketer of medical devices that are used in a range of interventional medical specialties. During the year ended December 31, 2010, the Company's products were offered for sale by seven business groups: CRM, Cardiovascular, including International Cardiology and Peripheral Interventions businesses; Electrophysiology; Endoscopy; Urology/Women's Health; Neuromodulation, and Neurovascular. During 2010, it had 28% of net sales from CRM business, 42% from Cardiovascular group, 2% from Electrophysiology business, 14% form Endoscopy business, 6% from Urology/Women's Health business, 4% from Neuromodulation business, and 4% from Neurovascular business. In October 2010, the Company acquired Asthmatx, Inc. In January 2011, the Company acquired Intelect Medical, Inc. In March 2011, the Company acquired Atritech, Inc. In January 2011, it sold its Neurovascular business to Stryker Corporation. |
